February 5, 2026
Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants
November 20, 2025
Merck Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for WINREVAIR® (sotatercept)
November 5, 2025
Quebec Expands Public Funding for CAPVAXIVE®
No current content.
